- Home
- AESI vs CDTX Comparison
AESI vs CDTX Comparison
Compare AESI & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AESI
- CDTX
- Stock Information
- Founded
- AESI 2017
- CDTX 2012
- Country
- AESI United States
- CDTX United States
- Employees
- AESI N/A
- CDTX 73
- Industry
- AESI Metal Fabrications
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AESI Industrials
- CDTX Health Care
- Exchange
- AESI Nasdaq
- CDTX Nasdaq
- Market Cap
- AESI 1.7B
- CDTX 1.6B
- IPO Year
- AESI 2023
- CDTX 2015
- Fundamental
- Price
- AESI $10.81
- CDTX $65.50
- Analyst Decision
- AESI Buy
- CDTX Strong Buy
- Analyst Count
- AESI 8
- CDTX 11
- Target Price
- AESI $18.81
- CDTX $57.00
- AVG Volume (30 Days)
- AESI 1.5M
- CDTX 489.9K
- Earning Date
- AESI 10-27-2025
- CDTX 11-06-2025
- Dividend Yield
- AESI 9.15%
- CDTX N/A
- EPS Growth
- AESI N/A
- CDTX N/A
- EPS
- AESI 0.12
- CDTX N/A
- Revenue
- AESI $1,162,039,000.00
- CDTX N/A
- Revenue This Year
- AESI $9.76
- CDTX N/A
- Revenue Next Year
- AESI $5.69
- CDTX N/A
- P/E Ratio
- AESI $94.60
- CDTX N/A
- Revenue Growth
- AESI 49.18
- CDTX N/A
- 52 Week Low
- AESI $10.40
- CDTX $10.14
- 52 Week High
- AESI $26.86
- CDTX $69.36
- Technical
- Relative Strength Index (RSI)
- AESI 38.47
- CDTX 58.07
- Support Level
- AESI $10.40
- CDTX $61.10
- Resistance Level
- AESI $11.04
- CDTX $65.84
- Average True Range (ATR)
- AESI 0.38
- CDTX 3.05
- MACD
- AESI 0.01
- CDTX -0.42
- Stochastic Oscillator
- AESI 26.82
- CDTX 71.23
About AESI Atlas Energy Solutions Inc.
Atlas Energy Solutions Inc is a provider of proppant and logistics services to the oil and natural gas industry within the Permian Basin of West Texas and New Mexico, the most active oil and natural gas basin in North America. Proppant is necessary to facilitate the recovery of hydrocarbons from oil and natural gas wells. One hundred percent of its sand reserves are located in Winkler and Ward Counties, Texas, within the Permian Basin, and its operations consist of proppant production and processing facilities, including two facilities near Kermit, Texas, and a third facility near Monahans, Texas.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.